semaglutide and cardiac risk cardiovascular outcomes study news reduction with once-weekly in subjects with type 2 diabetes: a post hoc analysis of gender, age, oral semaglutide cardiovascular benefit found

Semaglutide produced mean weight loss of 9.215.3% of baseline body weight across STEP trials

TB-500 (Thymosin Beta-4): Reduces inflammation, promotes angiogenesis (new blood vessel formation), and aids tissue repair and wound healing

Gender-affirming care for youth involves the use of puberty-blocking drugs, cross-sex hormones, and surgeries to treat children who experience distress associated with their sex

This article was updated on May 25 with Noom's weight-loss offering

The brand names Ozempic and Wegovy are commonly used for semaglutide, depending on whether the drug is being used to treat diabetes or assist with weight loss

Let's Explore Your GLP-1 Options